** Shares of vaccine maker Novavax NVAX.O gain 4.6% to $8.80 premarket
** NVAX to sell its Czech Republic manufacturing facility to Novo Nordisk NOVOb.CO for $200 mln, co says
** NVAX expects to reduce annual operating costs by ~$80 mln
** The deal expected to close by Dec. 30
** NOVO up 0.5% at $109.73 premarket
** 3 of 6 brokerages rate NVAX "buy" or higher, 2 "hold" and 1 "sell"; their median PT is $19 - LSEG
** As of last close, NVAX has risen 75.2% YTD
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。